Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02520427
Title A Phase 1 Study of AMG 330 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | DEU | CAN

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294-3300 United States Details
Research Site Duarte California 91010 United States Details
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Universitätsklinikum Schleswig-Holstein Kiel 24105 Germany Details
Klinikum der Universität München Campus Grosshadern München 81377 Germany Details
Universitatsklinikum Ulm Ulm 89081 Germany Details
Research Site Amsterdam 1007 MB Netherlands Details
Erasmus Medisch Centrum Rotterdam 3015 CE Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field